Law ❯ Securities Law

Litigation

Class Action Investor Rights Investor Protection Class Actions Corporate Governance Securities Litigation Supreme Court Shareholder Rights Class Action Lawsuits Securities Fraud

Investor Lawsuits Target ImmunityBio’s Anktiva After FDA Ad Rebuke

Investor firms are pushing to appoint a lead plaintiff by May 26 following an FDA finding that Anktiva promotions misled patients and investors.

Lufax Investors Urged to Seek Lead Role in Securities Suit as May 20 Deadline Nears

Concorde Investors Urged to Seek Lead Plaintiff by May 20 in Securities Suit

monday.com Investors Face May 11 Deadline in Securities Class Action

Atara Biotherapeutics Hit With Investor Class Action as Firms Press May 22 Lead-Plaintiff Deadline

Apollo Faces Securities Class Action Over Epstein Disclosures

Upstart Hit With Securities Class Action Over Alleged Misstatements About AI Model

Driven Brands Investor Lawsuits Expand as Firms Press May 8 Lead‑Plaintiff Deadline

Trip.com Investors Sought to Lead U.S. Securities Case as May 11 Deadline Nears

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Super Micro Faces Investor Class Actions After DOJ China-Export Indictment

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

Trip.com Investors Urged to Seek Lead Role in Securities Suit Before May 11 Deadline

New Kyndryl Class Action Filing Expands Investor Window, Alleges Inflated Cash Flow

Eos Energy Investors Face May 5 Deadline to Seek Lead Role in Securities Class Action

Enphase Investor Suits Intensify as Firms Push April 20 Lead-Plaintiff Deadline

Plaintiff Firms Step Up uniQure Solicitation After FDA Rebuke, With April 13 Lead-Plaintiff Deadline

Trip.com Faces U.S. Investor Lawsuits After Disclosing Chinese Antitrust Probe

Navan Faces Securities Class Action Over IPO Disclosures as Lead-Plaintiff Push Builds

Driven Brands Sued Over Accounting Restatement With Lead‑Plaintiff Deadline Set for May 8